HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brachydactyly

Congenital anomaly of abnormally short fingers or toes.
Also Known As:
Brachydactylia; Brachydactylism; Brachydactylias; Brachydactylies; Brachydactylisms
Networked: 129 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Syndactyly (Polysyndactyly)
2. Polydactyly (Polydactylism)
3. Congenital Abnormalities (Deformity)
4. Neoplasms (Cancer)
5. Pseudohypoparathyroidism

Experts

1. Stricker, Sigmar: 4 articles (11/2012 - 03/2002)
2. Pereda, Arrate: 3 articles (01/2020 - 11/2014)
3. Silve, Caroline: 3 articles (01/2020 - 10/2017)
4. Cormier-Daire, Valérie: 3 articles (11/2018 - 11/2004)
5. Munnich, Arnold: 3 articles (11/2018 - 11/2004)
6. Luft, Friedrich C: 3 articles (11/2012 - 04/2002)
7. Mundlos, Stefan: 3 articles (11/2009 - 03/2002)
8. Offiah, Amaka: 2 articles (01/2022 - 01/2018)
9. Wang, Jian: 2 articles (01/2022 - 06/2015)
10. An, Yu: 2 articles (01/2021 - 06/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Brachydactyly:
1. Hormones (Hormone)IBA
2. Parathyroid Hormone (Parathormone)IBA
3. Long Noncoding RNAIBA
4. Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
5. Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
12/01/2016 - "In older children, moderate mental retardation, brachydactyly, afebrile seizures, short stature, and thyroid-stimulating hormone resistance are the most suggestive features."
05/22/2020 - "Biochemical and imaging findings were consistent with PHP-Ia, including typical Albright hereditary osteodystrophy phenotype (short stature, round face, brachydactyly, and mild mental retardation), PTH resistance (hypocalcemia, hyperphosphatemia, elevated serum PTH, and multiple intracranial calcification) and thyroid stimulating hormone resistance (elevated serum thyroid stimulating hormone). "
11/01/2000 - "One patient has mild brachydactyly but no endocrinopathy, whereas the other manifests brachydactyly, obesity, and target tissue resistance to thyrotropin and parathyroid hormone (PTH). "
10/18/2023 - "Many clinical features including obesity, neurocognitive impairment, brachydactyly, short stature, parathyroid hormone (PTH) resistance, and resistance to other hormones such as thyroid-stimulating hormone (TSH) have been well described, yet they refer mainly to the full development of the disease during late childhood and adulthood. "
01/01/2018 - "Although (epi)genotype-phenotype findings were grossly similar to those reported previously, several important findings were identified, including younger age at hypocalcemic symptoms and higher frequencies of hyperphosphatemia in subgroup C than in subgroup D, development of brachydactyly in four patients of subgroup C, predominant manifestation of subcutaneous ossification in subgroup B, higher frequency of thyrotropin resistance in group 1 than in group 2, and relatively low thyrotropin values in four patients with low T4 values and relatively low luteinizing hormone/follicle-stimulating hormone values in five adult females with ovarian dysfunction. "
6. Proteins (Proteins, Gene)FDA Link
7. 5-phenylpent-4-enyl-1-hydroperoxideIBA
8. polyalanineIBA
9. Growth Hormone (Somatotropin)IBA
10. GonadotropinsIBA

Therapies and Procedures

1. Skin Transplantation (Skin Grafting)
2. Sutures (Suture)
3. Lenses
4. Osteotomy
5. Surgical Amputation (Amputations)